HomeMNMD • NASDAQ
add
Mind Medicine (MindMed) Inc
Previous close
$11.81
Day range
$12.16 - $12.75
Year range
$4.70 - $12.94
Market cap
932.08M USD
Avg Volume
1.61M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 40.90M | 67.24% |
Net income | -42.74M | -630.17% |
Net profit margin | — | — |
Earnings per share | -0.69 | -138.61% |
EBITDA | -40.90M | -67.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 182.99M | -24.74% |
Total assets | 265.09M | -1.14% |
Total liabilities | 79.69M | 20.56% |
Total equity | 185.40M | — |
Shares outstanding | 76.09M | — |
Price to book | 4.82 | — |
Return on assets | -37.84% | — |
Return on capital | -43.38% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -42.74M | -630.17% |
Cash from operations | -29.60M | -48.08% |
Cash from investing | -39.54M | — |
Cash from financing | 19.65M | 82.15% |
Net change in cash | -49.46M | -437.63% |
Free cash flow | -11.18M | 68.05% |
About
Mind Medicine Inc., doing business as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
Founded
2010
Website
Employees
74
